Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China

被引:9
作者
He, Xinyue [1 ]
Tian, Zhuang [1 ,2 ]
Guan, Hongzhi [3 ]
Zhang, Shuyang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China
关键词
Transthyretin amyloidosis; Rare disease; Hereditary; Chinese; VITREOUS AMYLOIDOSIS; POLYNEUROPATHY; MUTATION; GLY83ARG;
D O I
10.1186/s13023-022-02481-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), chi(2) = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Hereditary transthyretin amyloidosis: a case report
    Lee, Angela
    Fine, Nowell M.
    Bril, Vera
    Delgado, Diego
    Hahn, Christopher
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [42] Hereditary transthyretin amyloidosis: current treatment
    Adams, David
    Slama, Michel
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (05) : 553 - 561
  • [43] Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)
    Zibert, Andree
    Huesing-Kabar, Anna
    Schmidt, Hartmut
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (20) : 1438 - 1443
  • [44] Hereditary transthyretin amyloidosis: a case report
    Angela Lee
    Nowell M. Fine
    Vera Bril
    Diego Delgado
    Christopher Hahn
    Journal of Medical Case Reports, 16
  • [45] Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)
    Gonzalez-Duarte, Alejandra
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (02) : 245 - 251
  • [46] Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study
    Gaya-Barroso, Aina
    Gonzalez-Moreno, Juan
    Rodriguez, Adrian
    Ripoll-Vera, Tomas
    Losada-Lopez, Ines
    Gili, Margarita
    Paneque, Milena
    Perez-Martinez, Sara
    Cisneros-Barroso, Eugenia
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [47] Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis
    Vilas-Boas, Maria do Carmo
    Rocha, Ana Patricia
    Cardoso, Marcio Neves
    Fernandes, Jose Maria
    Coelho, Teresa
    Cunha, Joao Paulo Silva
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [48] Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis
    Gawor, Monika
    Holcman, Katarzyna
    Franaszczyk, Maria
    Lipowska, Marta
    Michalek, Piotr
    Teresinska, Anna
    Bilinska, Zofia T.
    Rubis, Pawel
    Kostkiewicz, Magdalena
    Szot, Wojciech
    Podolec, Piotr
    Grzybowski, Jacek
    CARDIOLOGY JOURNAL, 2020, : 985 - 993
  • [49] Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
    Gonzalez-Moreno, Juan
    Dispenzieri, Angela
    Grogan, Martha
    Coelho, Teresa
    Tournev, Ivailo
    Waddington-Cruz, Marcia
    Wixner, Jonas
    Diemberger, Igor
    Garcia-Pavia, Pablo
    Chapman, Doug
    Gupta, Pritam
    Glass, Oliver
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 117 - 135
  • [50] NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Conceicao, Isabel
    Wixner, Jonas
    Berk, John
    Adams, David
    Polydefkis, Michael
    Attarian, Shahram
    Gillmore, Julian
    Dyck, P. James
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S138